Effect of RDX-002 on Postprandial Triglycerides in Subjects Treated With Olanzapine

NCT05857566 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Drug-induced Weight Gain

Interventions

DRUG: RDX-002

Sponsor

Response Pharmaceuticals